Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 588 entries
Sorted by: Best Match Show Resources per page
Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial.

Journal of cachexia, sarcopenia and muscle

Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K.
PMID: 24052226
J Cachexia Sarcopenia Muscle. 2013 Dec;4(4):247-57. doi: 10.1007/s13539-013-0115-9. Epub 2013 Sep 20.

BACKGROUND: Low serum albumin is common and associated with protein-energy wasting, inflammation, and poor outcomes in maintenance hemodialysis (MHD) patients. We hypothesized that in-center (in dialysis clinic) provision of high-protein oral nutrition supplements (ONS) tailored for MHD patients combined...

Cite
Rattanasompattikul M, Molnar MZ, Lee ML, et al. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle. 2013;4(4):247-57doi: 10.1007/s13539-013-0115-9.
Rattanasompattikul, M., Molnar, M. Z., Lee, M. L., Dukkipati, R., Bross, R., Jing, J., Kim, Y., Voss, A. C., Benner, D., Feroze, U., Macdougall, I. C., Tayek, J. A., Norris, K. C., Kopple, J. D., Unruh, M., Kovesdy, C. P., & Kalantar-Zadeh, K. (2013). Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. Journal of cachexia, sarcopenia and muscle, 4(4), 247-57. https://doi.org/10.1007/s13539-013-0115-9
Rattanasompattikul, Manoch, et al. "Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial." Journal of cachexia, sarcopenia and muscle vol. 4,4 (2013): 247-57. doi: https://doi.org/10.1007/s13539-013-0115-9
Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle. 2013 Dec;4(4):247-57. doi: 10.1007/s13539-013-0115-9. Epub 2013 Sep 20. PMID: 24052226; PMCID: PMC3830006.
Copy Download .nbib Format: NLM
Discussion around statin discontinuation in older adults and patients with wasting diseases.

Journal of cachexia, sarcopenia and muscle

Banach M, Serban MC.
PMID: 27030814
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):396-9. doi: 10.1002/jcsm.12109. Epub 2016 Feb 29.

No abstract available.

Cite
Banach M, Serban MC. Discussion around statin discontinuation in older adults and patients with wasting diseases. J Cachexia Sarcopenia Muscle. 2016;7(4):396-9doi: 10.1002/jcsm.12109.
Banach, M., & Serban, M. C. (2016). Discussion around statin discontinuation in older adults and patients with wasting diseases. Journal of cachexia, sarcopenia and muscle, 7(4), 396-9. https://doi.org/10.1002/jcsm.12109
Banach, Maciej, and Serban, Maria-Corina. "Discussion around statin discontinuation in older adults and patients with wasting diseases." Journal of cachexia, sarcopenia and muscle vol. 7,4 (2016): 396-9. doi: https://doi.org/10.1002/jcsm.12109
Banach M, Serban MC. Discussion around statin discontinuation in older adults and patients with wasting diseases. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):396-9. doi: 10.1002/jcsm.12109. Epub 2016 Feb 29. PMID: 27030814; PMCID: PMC4782254.
Copy Download .nbib Format: NLM
Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice.

Journal of cachexia, sarcopenia and muscle

van Norren K, Rusli F, van Dijk M, Lute C, Nagel J, Dijk FJ, Dwarkasing J, Boekschoten MV, Luiking Y, Witkamp RF, Müller M, Steegenga WT.
PMID: 26401472
J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):253-68. doi: 10.1002/jcsm.12024. Epub 2015 Apr 27.

BACKGROUND: In rodent models, caloric restriction (CR) with maintenance of adequate micronutrient supply has been reported to increase lifespan and to reduce age-induced muscle loss (sarcopenia) during ageing. In the present study, we further investigated effects of CR on...

Cite
van Norren K, Rusli F, van Dijk M, et al. Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice. J Cachexia Sarcopenia Muscle. 2015;6(3):253-68doi: 10.1002/jcsm.12024.
van Norren, K., Rusli, F., van Dijk, M., Lute, C., Nagel, J., Dijk, F. J., Dwarkasing, J., Boekschoten, M. V., Luiking, Y., Witkamp, R. F., Müller, M., & Steegenga, W. T. (2015). Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice. Journal of cachexia, sarcopenia and muscle, 6(3), 253-68. https://doi.org/10.1002/jcsm.12024
van Norren, Klaske, et al. "Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice." Journal of cachexia, sarcopenia and muscle vol. 6,3 (2015): 253-68. doi: https://doi.org/10.1002/jcsm.12024
van Norren K, Rusli F, van Dijk M, Lute C, Nagel J, Dijk FJ, Dwarkasing J, Boekschoten MV, Luiking Y, Witkamp RF, Müller M, Steegenga WT. Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice. J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):253-68. doi: 10.1002/jcsm.12024. Epub 2015 Apr 27. PMID: 26401472; PMCID: PMC4575557.
Copy Download .nbib Format: NLM
Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review.

Journal of cachexia, sarcopenia and muscle

Grande AJ, Silva V, Maddocks M.
PMID: 26401466
J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):208-11. doi: 10.1002/jcsm.12055. Epub 2015 Jul 07.

BACKGROUND: Cancer cachexia is a complex syndrome characterized by an ongoing loss of skeletal muscle mass and progressive functional impairment. A proactive management approach is recommended, including physical exercise to maintain function via modulation of muscle metabolism, insulin sensitivity...

Cite
Grande AJ, Silva V, Maddocks M. Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2015;6(3):208-11doi: 10.1002/jcsm.12055.
Grande, A. J., Silva, V., & Maddocks, M. (2015). Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review. Journal of cachexia, sarcopenia and muscle, 6(3), 208-11. https://doi.org/10.1002/jcsm.12055
Grande, Antonio Jose, et al. "Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review." Journal of cachexia, sarcopenia and muscle vol. 6,3 (2015): 208-11. doi: https://doi.org/10.1002/jcsm.12055
Grande AJ, Silva V, Maddocks M. Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):208-11. doi: 10.1002/jcsm.12055. Epub 2015 Jul 07. PMID: 26401466; PMCID: PMC4575551.
Copy Download .nbib Format: NLM
Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat.

Journal of cachexia, sarcopenia and muscle

Kob R, Fellner C, Bertsch T, Wittmann A, Mishura D, Sieber CC, Fischer BE, Stroszczynski C, Bollheimer CL.
PMID: 26136194
J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):181-91. doi: 10.1002/jcsm.12019. Epub 2015 Apr 30.

BACKGROUND: Sarcopenia is linked to functional impairments, loss of independence, and mortality. In the past few years, obesity has been established as being a risk factor for a decline in muscle mass and function. There are several molecular pathological...

Cite
Kob R, Fellner C, Bertsch T, et al. Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat. J Cachexia Sarcopenia Muscle. 2015;6(2):181-91doi: 10.1002/jcsm.12019.
Kob, R., Fellner, C., Bertsch, T., Wittmann, A., Mishura, D., Sieber, C. C., Fischer, B. E., Stroszczynski, C., & Bollheimer, C. L. (2015). Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat. Journal of cachexia, sarcopenia and muscle, 6(2), 181-91. https://doi.org/10.1002/jcsm.12019
Kob, Robert, et al. "Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat." Journal of cachexia, sarcopenia and muscle vol. 6,2 (2015): 181-91. doi: https://doi.org/10.1002/jcsm.12019
Kob R, Fellner C, Bertsch T, Wittmann A, Mishura D, Sieber CC, Fischer BE, Stroszczynski C, Bollheimer CL. Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat. J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):181-91. doi: 10.1002/jcsm.12019. Epub 2015 Apr 30. PMID: 26136194; PMCID: PMC4458084.
Copy Download .nbib Format: NLM
Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction.

Journal of cachexia, sarcopenia and muscle

Faber J, Uitdehaag MJ, Spaander M, van Steenbergen-Langeveld S, Vos P, Berkhout M, Lamers C, Rümke H, Tilanus H, Siersema P, van Helvoort A, van der Gaast A.
PMID: 26136410
J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):32-44. doi: 10.1002/jcsm.12009. Epub 2015 Mar 31.

BACKGROUND: The majority of cancer patients loses weight and becomes malnourished during the course of their disease. Metabolic alterations and reduced immune competence lead to wasting and an increased risk of infectious complications. In the present study, the effect...

Cite
Faber J, Uitdehaag MJ, Spaander M, et al. Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. J Cachexia Sarcopenia Muscle. 2015;6(1):32-44doi: 10.1002/jcsm.12009.
Faber, J., Uitdehaag, M. J., Spaander, M., van Steenbergen-Langeveld, S., Vos, P., Berkhout, M., Lamers, C., Rümke, H., Tilanus, H., Siersema, P., van Helvoort, A., & van der Gaast, A. (2015). Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. Journal of cachexia, sarcopenia and muscle, 6(1), 32-44. https://doi.org/10.1002/jcsm.12009
Faber, Joyce, et al. "Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction." Journal of cachexia, sarcopenia and muscle vol. 6,1 (2015): 32-44. doi: https://doi.org/10.1002/jcsm.12009
Faber J, Uitdehaag MJ, Spaander M, van Steenbergen-Langeveld S, Vos P, Berkhout M, Lamers C, Rümke H, Tilanus H, Siersema P, van Helvoort A, van der Gaast A. Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):32-44. doi: 10.1002/jcsm.12009. Epub 2015 Mar 31. PMID: 26136410; PMCID: PMC4435095.
Copy Download .nbib Format: NLM
Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic.

Journal of cachexia, sarcopenia and muscle

Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, Bruera E.
PMID: 26136416
J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):95-8. doi: 10.1002/jcsm.12014. Epub 2015 Mar 31.

BACKGROUND: Elevated resting energy expenditure (REE) may contribute to weight loss and symptom burden in cancer patients.AIMS: The aim of this study was to compare the velocity of weight loss, symptom burden (fatigue, insomnia, anxiety, and anorexia-combined score as...

Cite
Dev R, Hui D, Chisholm G, et al. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle. 2015;6(1):95-8doi: 10.1002/jcsm.12014.
Dev, R., Hui, D., Chisholm, G., Delgado-Guay, M., Dalal, S., Del Fabbro, E., & Bruera, E. (2015). Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. Journal of cachexia, sarcopenia and muscle, 6(1), 95-8. https://doi.org/10.1002/jcsm.12014
Dev, Rony, et al. "Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic." Journal of cachexia, sarcopenia and muscle vol. 6,1 (2015): 95-8. doi: https://doi.org/10.1002/jcsm.12014
Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, Bruera E. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):95-8. doi: 10.1002/jcsm.12014. Epub 2015 Mar 31. PMID: 26136416; PMCID: PMC4435101.
Copy Download .nbib Format: NLM
Cachexia: a problem of energetic inefficiency.

Journal of cachexia, sarcopenia and muscle

Argilés JM, Fontes-Oliveira CC, Toledo M, López-Soriano FJ, Busquets S.
PMID: 25118829
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):279-86. doi: 10.1007/s13539-014-0154-x. Epub 2014 Aug 15.

An alteration of energy balance is the immediate cause of the so-called cachexia. Although alterations of energy intake are often associated with cachexia, it has lately became clear that an increased energy expenditure is the main cause of wasting...

Cite
Argilés JM, Fontes-Oliveira CC, Toledo M, et al. Cachexia: a problem of energetic inefficiency. J Cachexia Sarcopenia Muscle. 2014;5(4):279-86doi: 10.1007/s13539-014-0154-x.
Argilés, J. M., Fontes-Oliveira, C. C., Toledo, M., López-Soriano, F. J., & Busquets, S. (2014). Cachexia: a problem of energetic inefficiency. Journal of cachexia, sarcopenia and muscle, 5(4), 279-86. https://doi.org/10.1007/s13539-014-0154-x
Argilés, Josep M, et al. "Cachexia: a problem of energetic inefficiency." Journal of cachexia, sarcopenia and muscle vol. 5,4 (2014): 279-86. doi: https://doi.org/10.1007/s13539-014-0154-x
Argilés JM, Fontes-Oliveira CC, Toledo M, López-Soriano FJ, Busquets S. Cachexia: a problem of energetic inefficiency. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):279-86. doi: 10.1007/s13539-014-0154-x. Epub 2014 Aug 15. PMID: 25118829; PMCID: PMC4248416.
Copy Download .nbib Format: NLM
Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D.

Journal of cachexia, sarcopenia and muscle

Stimpson SA, Leonard MS, Clifton LG, Poole JC, Turner SM, Shearer TW, Remlinger KS, Clark RV, Hellerstein MK, Evans WJ.
PMID: 23797207
J Cachexia Sarcopenia Muscle. 2013 Jun 25; doi: 10.1007/s13539-013-0110-1. Epub 2013 Jun 25.

BACKGROUND: We recently validated in cross-sectional studies a new method to determine total body creatine pool size and skeletal muscle mass based on DMETHODS: Rats were given an oral tracer dose of DRESULTS: At 10 weeks of age, rat...

Cite
Stimpson SA, Leonard MS, Clifton LG, et al. Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D. J Cachexia Sarcopenia Muscle. 2013;doi: 10.1007/s13539-013-0110-1.
Stimpson, S. A., Leonard, M. S., Clifton, L. G., Poole, J. C., Turner, S. M., Shearer, T. W., Remlinger, K. S., Clark, R. V., Hellerstein, M. K., & Evans, W. J. (2013). Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D. Journal of cachexia, sarcopenia and muscle, . https://doi.org/10.1007/s13539-013-0110-1
Stimpson, Stephen A, et al. "Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D." Journal of cachexia, sarcopenia and muscle vol. (2013). doi: https://doi.org/10.1007/s13539-013-0110-1
Stimpson SA, Leonard MS, Clifton LG, Poole JC, Turner SM, Shearer TW, Remlinger KS, Clark RV, Hellerstein MK, Evans WJ. Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D. J Cachexia Sarcopenia Muscle. 2013 Jun 25; doi: 10.1007/s13539-013-0110-1. Epub 2013 Jun 25. PMID: 23797207; PMCID: PMC3774916.
Copy Download .nbib Format: NLM
An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada.

Journal of cachexia, sarcopenia and muscle

Guttridge D, Couch M, Di Marco S, Gallouzi IE, Zitzmann ND, Baracos V, Rudnicki M, Tremblay M, Zimmers T.
PMID: 24965540
J Cachexia Sarcopenia Muscle. 2014 Sep;5(3):181. doi: 10.1007/s13539-014-0150-1. Epub 2014 Jun 26.

No abstract available.

Cite
Guttridge D, Couch M, Di Marco S, et al. An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada. J Cachexia Sarcopenia Muscle. 2014;5(3):181doi: 10.1007/s13539-014-0150-1.
Guttridge, D., Couch, M., Di Marco, S., Gallouzi, I. E., Zitzmann, N. D., Baracos, V., Rudnicki, M., Tremblay, M., & Zimmers, T. (2014). An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada. Journal of cachexia, sarcopenia and muscle, 5(3), 181. https://doi.org/10.1007/s13539-014-0150-1
Guttridge, Denis, et al. "An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada." Journal of cachexia, sarcopenia and muscle vol. 5,3 (2014): 181. doi: https://doi.org/10.1007/s13539-014-0150-1
Guttridge D, Couch M, Di Marco S, Gallouzi IE, Zitzmann ND, Baracos V, Rudnicki M, Tremblay M, Zimmers T. An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada. J Cachexia Sarcopenia Muscle. 2014 Sep;5(3):181. doi: 10.1007/s13539-014-0150-1. Epub 2014 Jun 26. PMID: 24965540; PMCID: PMC4159485.
Copy Download .nbib Format: NLM
Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults.

Journal of cachexia, sarcopenia and muscle

Foong YC, Chherawala N, Aitken D, Scott D, Winzenberg T, Jones G.
PMID: 27239404
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):275-83. doi: 10.1002/jcsm.12065. Epub 2015 Oct 15.

INTRODUCTION: The aim of this study was to describe the relationship between accelerometer-determined physical activity (PA), muscle mass, and lower-limb strength in community-dwelling older adults.METHODS: Six hundred thirty-six community-dwelling older adults (66 ± 7 years) were studied. Muscle mass...

Cite
Foong YC, Chherawala N, Aitken D, et al. Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2015;7(3):275-83doi: 10.1002/jcsm.12065.
Foong, Y. C., Chherawala, N., Aitken, D., Scott, D., Winzenberg, T., & Jones, G. (2016). Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults. Journal of cachexia, sarcopenia and muscle, 7(3), 275-83. https://doi.org/10.1002/jcsm.12065
Foong, Yi Chao, et al. "Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults." Journal of cachexia, sarcopenia and muscle vol. 7,3 (2016): 275-83. doi: https://doi.org/10.1002/jcsm.12065
Foong YC, Chherawala N, Aitken D, Scott D, Winzenberg T, Jones G. Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):275-83. doi: 10.1002/jcsm.12065. Epub 2015 Oct 15. PMID: 27239404; PMCID: PMC4863829.
Copy Download .nbib Format: NLM
Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo.

Journal of cachexia, sarcopenia and muscle

Patel MS, Lee J, Baz M, Wells CE, Bloch S, Lewis A, Donaldson AV, Garfield BE, Hopkinson NS, Natanek A, Man WD, Wells DJ, Baker EH, Polkey MI, Kemp PR.
PMID: 27239406
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):436-48. doi: 10.1002/jcsm.12096. Epub 2015 Dec 29.

BACKGROUND: Loss of muscle mass is a co-morbidity common to a range of chronic diseases including chronic obstructive pulmonary disease (COPD). Several systemic features of COPD including increased inflammatory signalling, oxidative stress, and hypoxia are known to increase the...

Cite
Patel MS, Lee J, Baz M, et al. Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. J Cachexia Sarcopenia Muscle. 2015;7(4):436-48doi: 10.1002/jcsm.12096.
Patel, M. S., Lee, J., Baz, M., Wells, C. E., Bloch, S., Lewis, A., Donaldson, A. V., Garfield, B. E., Hopkinson, N. S., Natanek, A., Man, W. D., Wells, D. J., Baker, E. H., Polkey, M. I., & Kemp, P. R. (2016). Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. Journal of cachexia, sarcopenia and muscle, 7(4), 436-48. https://doi.org/10.1002/jcsm.12096
Patel, Mehul S, et al. "Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo." Journal of cachexia, sarcopenia and muscle vol. 7,4 (2016): 436-48. doi: https://doi.org/10.1002/jcsm.12096
Patel MS, Lee J, Baz M, Wells CE, Bloch S, Lewis A, Donaldson AV, Garfield BE, Hopkinson NS, Natanek A, Man WD, Wells DJ, Baker EH, Polkey MI, Kemp PR. Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):436-48. doi: 10.1002/jcsm.12096. Epub 2015 Dec 29. PMID: 27239406; PMCID: PMC4864181.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 588 entries